• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Port Info

• Ships in Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• The Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

HYDERABAD: Reliance Capital Asset Management Ltd has informed the stock exchanges that Reliance Vision Fund, scheme of Reliance Mutual Fund, and Reliance Portfolio Management (acquirer and persons acting in concert) have acquired further shares in Divi's Laboratories Ltd, a Hyderabad-based pharmaceutical company.

Reliance Mutual Fund Scheme has acquired 29,847 shares aggregating to 0.23 per cent of total paid up capital of Divi's Labs on September 27 through open market purchase.

Following this, the total shareholding of Reliance Vision Fund and Reliance Portfolio Management in Divi's Labs increased to 6,51,837 shares aggregating to 5.08 per cent of the latter's paid-up capital.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
WHO relists Ranbaxy's anti-retroviral Nevirapine

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line